Insider has been troubled about "doing the right thing" for some time. However, he has not yet left Big Pharma. Nonetheless, he needed to vent about a number of sharp practices the industry was rapidly making into an artform.
Pharma Watch have a great example today:
http://pharmawatch.blogspot.com/2005/10/cheats-guide-to-clinical-trials-15.html#comments
So, is insider being unethical in what he is doing now? Who better to ask than the Editor of the American Journal of Bioethics.
Lets see what develops?
PS: the blog is great!
No comments:
Post a Comment